4.6 Editorial Material

Editorial: Recent breakthroughs in the decoding of circulating nucleic acids and their applications to human diseases

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Circulating microRNAs as Reliable Tumor Biomarkers: Opportunities and Challenges Facing Clinical Application

Sherien M. El-Daly et al.

Summary: This article reviews the potential applications of cell-free circulating miRNAs as noninvasive biomarkers in clinical settings, as well as the importance of integrating them with standard laboratory biomarkers to improve sensitivity and specificity.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2023)

Review Biochemistry & Molecular Biology

Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments

Saife N. Lone et al.

Summary: Liquid biopsies are non-invasive methods that have revolutionized cancer diagnosis and monitoring. By analyzing tumor-derived entities in body fluids, liquid biopsies provide detailed information about tumor characteristics and can be used for detection, prognosis, and treatment monitoring.

MOLECULAR CANCER (2022)

Article Oncology

Liquid biopsy enters the clinic - implementation issues and future challenges

Michail Ignatiadis et al.

Summary: The approval of liquid biopsy assays for detecting genetic alterations in plasma cell-free DNA has marked a tipping point for the clinical use of this technology, especially in patients with advanced-stage cancer. The next frontier is likely to be the systemic treatment of patients with 'ctDNA relapse' and other potential future applications include cancer screening and diagnosis.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Multidisciplinary Sciences

Circulating microRNAs as stable blood-based markers for cancer detection

Patrick S. Mitchell et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)